NUCANA PLC ADS news, videos and press releases
For more news please use our advanced search feature.
NUCANA PLC ADS - More news...
NUCANA PLC ADS - More news...
- NuCana Announces Completion of ADS Ratio Change
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
- NuCana Announces Plan to Implement ADS Ratio Change
- NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
- NuCana to Present at TD Cowen’s 44th Annual Health Care Conference
- NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update
- NuCana Announces Listing Transfer to Nasdaq Capital Market
- NuCana to Present at the Jefferies London Healthcare Conference
- NuCana to Participate in the Truist Securities 2023 BioPharma Symposium
- NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
- NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
- NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
- NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update
- NuCana to Present at the Jefferies Healthcare Conference
- NuCana Reports First Quarter 2023 Financial Results and Provides Business Update
- NuCana Announces Receipt of Nasdaq Notice
- NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action
- NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update
- Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid
- NuCana to Participate in Two Upcoming Investor Conferences
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
- NuCana Announces Receipt of NASDAQ Notice
- NuCana to Host Investor Meetings During the J.P. Morgan Healthcare Conference
- NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update
- NuCana to Present at the Jefferies London Healthcare Conference
- NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022
- NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022
- NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022
- NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022
